Amber Howe - 01 Mar 2022 Form 4 Insider Report for American Well Corp (AMWL)

Signature
/s/ Bradford Gay, as attorney-in-fact for Amber Howe
Issuer symbol
AMWL
Transactions as of
01 Mar 2022
Net transactions value
-$685
Form type
4
Filing time
03 Mar 2022, 16:36:36 UTC
Previous filing
03 Dec 2021
Next filing
20 Apr 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMWL Class A Common Stock Sale $685 -174 -0.25% $3.94 70,738 01 Mar 2022 Direct F1
transaction AMWL Class A Common Stock Award $0 +232,428 +320% $0.000000 305,148 01 Mar 2022 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMWL Performance Share Units Award $0 +232,428 $0.000000 232,428 01 Mar 2022 Class A Common Stock 232,428 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was made in order to pay the tax liability arising from the vesting and settlement of restricted stock units on March 1, 2022. The sale was effected through an automatic "sell to cover" transaction that did not represent a discretionary trade by the reporting person.
F2 Represents a grant of restricted stock units, with 25% vesting upon the first anniversary of the grant date ("Initial Vesting Date"), and the remaining vesting every 3 months thereafter over a three-year period (beginning on the first calendar day of the month following the date that is three months following the Initial Vesting Date).
F3 Securities Beneficially Owned includes shares acquired pursuant to the Issuer's employee stock purchase plan in a transaction exempt under Rule 16b-3.
F4 Each Performance Share Unit represents a contingent right to receive one share of Class A Common Stock of the Issuer. The Performance Share Units are eligible to vest over a three-year performance period ending February 28, 2025, and may be earned between 0%-300% of target levels, based upon the Issuer's achievement of specified market capitalization performance thresholds, subject to the reporting person's continued employment through the date on which performance is certified.